ProPhase Labs, Inc. Quarterly report pursuant to Section 13 or 15(d)

Significant Customers (Details Narrative) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Net sales	$ 2,766	$ 2,439	$ 6,735	$ 9,033
Sales Revenue, Net [Member] \| Third Party Contract Manufacturing Customer One [Member]
Concentration risk, percentage	33.04%	38.90%	44.20%	39.80%
Sales Revenue, Net [Member] \| Third Party Contract Manufacturing Customer Two [Member]
Concentration risk, percentage	30.10%	30.40%	27.20%	39.00%
Sales Revenue, Net [Member] \| Third Party Contract Manufacturing Customer Three [Member]
Concentration risk, percentage	10.20%	15.20%
Accounts Receivable [Member] \| Customer One [Member]
Concentration risk, percentage			62.50%
Accounts Receivable [Member] \| Customer Two [Member]
Concentration risk, percentage			20.10%
Accounts Receivable [Member] \| One Customer [Member]
Concentration risk, percentage					82.00%